Thompson Davis & Co’s Ambev ABEV Stock Holding History

Thompson Davis & Co’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-224	Closed	-$1K	–	660
2017 Q3	$1K	Buy	+224	New	+$1.39K	﹤0.01%	1049

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MNG

Manning & Napier Group Fairport, New York $8.76B AUM 23.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Thompson Davis & Co's ABEV Position: Q4 2017 in Review

Thompson Davis & Co sold out of Ambev (ABEV) in Q4 2017, closing a stake of 224 shares — an estimated $1K sold.

Thompson Davis & Co first reported a position in ABEV in Q3 2017 and held it in 1 quarter. The position peaked at $1K in Q3 2017. 328 funds tracked by Wall St. Rank hold ABEV as of Q4 2017.

Thompson Davis & Co reported no remaining Ambev position as of Q4 2017 after selling out during the quarter.
Thompson Davis & Co sold 224 Ambev shares in Q4 2017, an estimated $1K.
Thompson Davis & Co first reported a position in Ambev in Q3 2017 and held it in 1 quarter.
Thompson Davis & Co's Ambev position peaked at $1K in Q3 2017.
328 funds tracked by Wall St. Rank held Ambev as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.